Korro Announces Oversubscribed $85 Million Private Placement
- In health
- Mar 09, 2026, 11:30 AM
- By Korro Bio, Inc.
- 0 Views

CAMBRIDGE, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company developing a new class of genetic medicines based on editing RNA for rare and highly prevalent diseases, today announced it has entered in…
- Financing led by new investor Venrock Healthcare Capital Partners, with participation from new and existing investors
- Proceeds support the achievement of value inflection poi… [+8305 chars]
- health
- Mar 30, 2026, 03:28 AM
- health
- Mar 30, 2026, 03:21 AM
- health
- Mar 29, 2026, 10:34 PM
- health
- Mar 29, 2026, 05:34 PM
- health
- Mar 29, 2026, 12:30 PM
- health
- Mar 29, 2026, 12:22 PM
- health
- Mar 29, 2026, 12:20 PM
- health
- Mar 29, 2026, 12:18 PM
- health
- Mar 29, 2026, 12:16 PM
- health
- Mar 29, 2026, 12:16 PM